Genetic control of human NK cell repertoire

Journal of Immunology

Volumn 169, Issue 1, 2002, Pages 239-247

  Shilling, Heather G ^a   Young, Neil ^a   Guethlein, Lisbeth A ^a   Cheng, Nathalie W ^a   Gardiner, Clair M ^a   Tyan, Dolly ^a   Parham, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ARTICLE; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETIC REGULATION; HLA MATCHING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STABILITY; STEM CELL TRANSPLANTATION;

EID: 0036644057     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.1.239     Document Type: Article

References (57)

1. Biology of natural killer cells
2. Role of murine NK cells and their receptors in hybrid resistance
3. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation
4. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
5. NK cell receptors
6. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors
7. Human diversity in killer cell inhibitory receptor genes
8. Gene arrangement of the killer cell inhibitory receptor family on human chromosome 19q13.4 detected by fiber-FISH
9. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4
10. Plasticity in the organization and sequences of human KIR/ILT gene families
11. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
12. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
13. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
14. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes
15. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells
16. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells
17. Cloning of murine NKG2A, B and C: Second family of C-type lectin receptors on murine NK cells
18. A multigene family on human chromosome 12 encodes natural killer-cell lectins
19. The human natural killer gene complex is located on chromosome 12p12-p13
20. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex
21. Identification of a human member of the Ly-49 multigene family
22. The centromeric part of the human NK gene complex: Linkage of LOX-1 and LY49L with the CD94/NKG2 region
23. NK cells, MHC class I antigens and missing self
24. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype
25. The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes
26. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination
27. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires
28. Identification of seventeen novel KIR variants: Fourteen of them from two non-Caucasian donors
29. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DLI gene polymorphism
30. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups
31. Genomic diversity of natural killer cell receptor genes in three populations
32. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
33. High dose busulfan/etoposide as a preparatory regimen for second bone marrow transplants in hematologic malignancies
34. High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies
35. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies
36. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma
37. Inhibitory MHC class I receptors on NK and T cells: A standard nomenclature
38. Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR "B" haplotypes
39. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype
40. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
41. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones
42. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
43. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
44. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
45. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L- selectin
46. dim NK cells
47. Human natural killer cells with polyclonal lectin and immunoglobulin-like receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
48. Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mono-nuclear cells after allogeneic bone marrow transplantation
49. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand
50. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development
51. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice
52. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection
53. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire
54. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC
55. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells
56. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells
57. An alternatively spliced form of the human CD94 gene